Gala Therapeutics Overview
- Founded
-
2015

- Status
-
Private
- Employees
-
39

- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$100M
- Investors
-
1
Gala Therapeutics General Information
Description
Developer of disease-modifying therapies designed to improve survival, quality of life, and outcomes for patients with lung cancer, COPD (Chronic Obstructive Pulmonary Disease), asthma, and other pulmonary diseases. The company's system offers a single-use catheter and electrosurgical generator to deliver non-thermal energy to the airways to reduce mucus-producing cells in patients, enabling physicians to treat their patients better, resulting in a better medical outcome.
Contact Information
Website
www.galatherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Primary Office
- 1531 Industrial Road
- Suite 100
- San Carlos, CA 94070
- United States
+1 (650) 000-0000
Gala Therapeutics Timeline
Gala Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Later Stage VC (Series B) | 29-Mar-2022 | $100M | 00000 | 00000 | Completed | Generating Revenue |
1. Early Stage VC (Series A) | 18-Nov-2019 | 000.00 | 000.00 | 000.00 | Completed | Generating Revenue |
Gala Therapeutics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Series A | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Gala Therapeutics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of disease-modifying therapies designed to improve survival, quality of life, and outcomes for patients with l
Therapeutic Devices
San Carlos, CA
39
As of 2021
00000
0000
0000-00-00
00000000000
00000
Gala Therapeutics Competitors (3)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
RejuvenAir | Venture Capital-Backed | Lexington, MA | 00 | 00000 | 00000000000 | 00000 |
0000000 | Formerly VC-backed | Redwood City, CA | 000 | 00000 | 00000000 | 00000 |
0000000 | Venture Capital-Backed | Minneapolis, MN | 00 | 00000 | 0000000000 0 | 00000 |
Gala Therapeutics Executive Team (4)
Gala Therapeutics Board Members (5)
Name | Representing | Role | Since |
---|---|---|---|
Douglas Godshall | Self | Co-Chairman | 000 0000 |
Jonathan Waldstreicher MD | Self | Founder, Chief Executive Officer, President & Board Member | 000 0000 |
Seth Harrison MD | Self | Co-Chairman | 000 0000 |
Gala Therapeutics Signals
Gala Therapeutics Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
ATP (Apple Tree Partners) | Venture Capital | Minority | 000 0000 | 000000 0 |